Index NDX, S&P 500
P/E 48.61
EPS (ttm) 10.06
Insider Own 0.99%
Shs Outstand 83.03M
Perf Week 2.40%
Market Cap 40.65B
Forward P/E 38.28
EPS next Y 12.78
Insider Trans -8.03%
Shs Float 82.27M
Perf Month -7.79%
Income 845.04M
PEG 4.05
EPS next Q 2.70
Inst Own 90.19%
Short Float 2.08%
Perf Quarter -6.35%
Sales 3.66B
P/S 11.10
EPS this Y 11.09%
Inst Trans -0.23%
Short Ratio 4.09
Perf Half Y 13.57%
Book/sh 17.88
P/B 27.36
EPS next Y 14.36%
ROA 28.14%
Short Interest 1.71M
Perf Year 1.24%
Cash/sh 5.46
P/C 89.55
EPS next 5Y 12.00%
ROE 80.74%
52W Range 372.50 - 583.39
Perf YTD -11.86%
Dividend Est. -
P/FCF 52.60
EPS past 5Y 18.76%
ROI 38.29%
52W High -16.14%
Beta 1.27
Dividend TTM -
Quick Ratio 1.11
Sales past 5Y 10.69%
Gross Margin 59.73%
52W Low 31.34%
ATR (14) 11.38
Dividend Ex-Date -
Current Ratio 1.51
EPS Y/Y TTM 25.28%
Oper. Margin 29.88%
RSI (14) 36.24
Volatility 2.35% 2.07%
Employees 11000
Debt/Eq 0.72
Sales Y/Y TTM 8.72%
Profit Margin 23.08%
Recom 2.31
Target Price 620.56
Option/Short Yes / Yes
LT Debt/Eq 0.49
EPS Q/Q 12.80%
Payout 0.00%
Rel Volume 0.86
Prev Close 494.26
Sales Surprise 1.09%
EPS Surprise 9.22%
Sales Q/Q 8.81%
Earnings May 01 BMO
Avg Volume 418.29K
Price 489.24
SMA20 -3.27%
SMA50 -8.41%
SMA200 -3.00%
Trades
Volume 358,211
Change -1.02%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-30-24 Downgrade
Piper Sandler
Overweight → Neutral
$525
Dec-07-23 Initiated
Exane BNP Paribas
Outperform
$602
Dec-04-23 Upgrade
Cleveland Research
Neutral → Buy
Aug-02-23 Downgrade
Atlantic Equities
Overweight → Neutral
$610
Jul-25-22 Downgrade
Stifel
Buy → Hold
$415
Jul-21-22 Upgrade
Goldman
Neutral → Buy
$530 → $435
Jul-12-22 Initiated
Piper Sandler
Overweight
$440
May-05-22 Downgrade
BofA Securities
Buy → Neutral
$550 → $470
Feb-08-22 Initiated
Atlantic Equities
Overweight
$650
Nov-18-21 Initiated
Morgan Stanley
Overweight
Aug-05-21 Resumed
Credit Suisse
Outperform
$735
Jul-12-21 Downgrade
Guggenheim
Buy → Neutral
Feb-17-21 Initiated
Barclays
Overweight
$600
Sep-09-19 Initiated
Goldman
Neutral
$277
May-23-19 Initiated
Guggenheim
Buy
$276
Nov-02-18 Reiterated
BofA/Merrill
Buy
$275 → $235
May-07-18 Reiterated
Stifel
Buy
$215 → $225
Jan-16-18 Initiated
Piper Jaffray
Overweight
$200
Aug-23-17 Upgrade
BofA/Merrill
Neutral → Buy
Jul-28-17 Upgrade
CL King
Neutral → Buy
Show Previous Ratings
Apr-24-24 12:01PM
Apr-19-24 07:56AM
Apr-12-24 01:53PM
Apr-09-24 06:00PM
12:00PM
12:10PM
Loading…
Apr-05-24 12:10PM
Apr-04-24 04:30PM
Apr-02-24 08:31AM
Mar-29-24 02:15AM
Mar-21-24 05:42AM
Mar-08-24 03:01AM
Mar-06-24 11:30AM
Mar-05-24 03:05AM
Feb-22-24 03:46AM
Feb-20-24 02:00PM
01:26PM
Loading…
Feb-18-24 01:26PM
Feb-16-24 12:56PM
Feb-15-24 11:53AM
07:00AM
Feb-10-24 02:07AM
Feb-09-24 03:35PM
Feb-08-24 10:34AM
Feb-06-24 02:25PM
(Investor's Business Daily)
08:46AM
02:05AM
(Thomson Reuters StreetEvents)
Feb-05-24 10:31PM
(Morningstar Research) +8.53%
10:37AM
09:30AM
07:45AM
07:40AM
06:53AM
Loading…
06:53AM
06:39AM
(Associated Press Finance)
06:30AM
Feb-02-24 08:46AM
Jan-31-24 09:15AM
07:29AM
Jan-30-24 12:10PM
Jan-29-24 11:58AM
Jan-25-24 07:18AM
Jan-23-24 03:30PM
Jan-19-24 07:14AM
Jan-15-24 11:33AM
Jan-12-24 07:05AM
07:00AM
Jan-11-24 09:48PM
Dec-18-23 07:40AM
05:19AM
Dec-09-23 01:05AM
Dec-07-23 09:16PM
04:15PM
Dec-06-23 03:25PM
(Investor's Business Daily)
Dec-04-23 08:12PM
(Morningstar Research) +7.05%
Dec-01-23 11:31AM
Nov-16-23 09:28AM
Nov-13-23 06:10AM
Nov-11-23 12:00PM
Nov-09-23 07:48AM
Nov-08-23 07:00AM
Nov-02-23 06:55PM
08:52AM
01:10AM
12:45AM
(Thomson Reuters StreetEvents)
Nov-01-23 10:00PM
02:52PM
09:53AM
09:28AM
08:46AM
06:40AM
(Associated Press Finance)
06:30AM
Oct-31-23 11:25AM
Oct-25-23 10:02AM
Oct-23-23 06:19AM
Oct-13-23 11:40AM
Oct-06-23 07:30AM
Oct-05-23 04:00PM
Sep-28-23 10:12AM
Sep-19-23 01:08PM
Sep-13-23 07:39PM
Sep-08-23 12:04PM
Sep-06-23 11:14AM
Aug-31-23 11:31AM
07:14AM
04:35AM
Aug-29-23 12:06PM
11:35AM
Aug-27-23 08:44AM
Aug-25-23 04:30AM
(Zacks Small Cap Research)
Aug-23-23 09:26AM
Aug-18-23 11:04AM
Aug-13-23 07:00AM
Aug-08-23 07:01AM
Aug-05-23 09:15AM
Aug-03-23 09:01AM
Aug-02-23 02:06PM
Aug-01-23 10:20PM
(Thomson Reuters StreetEvents)
05:27PM
11:30AM
11:02AM
08:46AM
07:45AM
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. It operates through the following segments: Companion Animal Group (CAG), Water Quality Products (Water), Livestock, Poultry, and Dairy (LPD), and Other. The CAG segment provides diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment offers innovative testing solutions for easy, rapid, and accurate detection and quantification of various microbiological parameters in water. The LPD segment develops diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve producer efficiency, and to ensure the quality and safety of milk and food. The Other segment is composed of products for the human point-of-care medical diagnostics market with its out-licensing arrangements. The company was founded by David Evans Shaw on December 19, 1983, and is headquartered in Westbrook, ME.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Option Exercise 422.45 8,104 3,423,547 18,815 Mar 07 05:00 PM POLEWACZYK JAMES F Executive Vice President Mar 06 '24 Sale 558.44 8,104 4,525,596 10,711 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Option Exercise 245.79 1,404 345,089 2,620 Mar 07 05:00 PM Vandebroek Sophie V. Director Mar 05 '24 Sale 562.98 1,404 790,427 1,216 Mar 07 05:00 PM MAZELSKY JONATHAN JAY President and CEO Feb 21 '24 Option Exercise 206.94 483 99,952 82,047 Feb 22 05:02 PM Underberg Sharon E. EVP, GC & Corporate Secretary Feb 16 '24 Option Exercise 206.94 483 99,952 5,595 Feb 20 05:01 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 15 '24 Option Exercise 206.94 483 99,952 30,835 Feb 20 05:00 PM Smith Martin Alexander Executive Vice President Feb 14 '24 Option Exercise 0.00 337 0 583 Feb 16 05:58 PM Schreck Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 368 0 903 Feb 16 05:58 PM Johnson Michael Perkins EVP and CHRO Feb 14 '24 Option Exercise 0.00 176 0 243 Feb 16 05:56 PM Lane Michael Executive Vice President Feb 14 '24 Option Exercise 0.00 939 0 6,726 Feb 16 05:56 PM MAZELSKY JONATHAN JAY President and CEO Feb 14 '24 Option Exercise 0.00 4,156 0 83,403 Feb 16 05:56 PM Erickson Michael G Executive Vice President Feb 14 '24 Option Exercise 0.00 462 0 10,801 Feb 16 05:54 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 14 '24 Option Exercise 0.00 370 0 7,082 Feb 16 05:55 PM Hunt Nimrata Executive Vice President Feb 14 '24 Option Exercise 0.00 664 0 11,731 Feb 16 05:55 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 14 '24 Option Exercise 0.00 1,731 0 31,449 Feb 16 05:57 PM POLEWACZYK JAMES F Executive Vice President Feb 14 '24 Option Exercise 0.00 927 0 10,990 Feb 16 05:57 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Option Exercise 62.00 9,810 608,220 14,910 Feb 09 05:03 PM FENNELL GEORGE SVP, Chief Revenue Officer Feb 08 '24 Sale 573.87 8,198 4,704,559 6,712 Feb 09 05:03 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Option Exercise 141.60 23,326 3,302,962 53,044 Feb 09 05:01 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Option Exercise 67.85 12,000 814,200 91,247 Feb 09 05:00 PM MCKEON BRIAN P EVP, CFO and Treasurer Feb 07 '24 Sale 570.01 23,326 13,295,975 29,718 Feb 09 05:01 PM MAZELSKY JONATHAN JAY President and CEO Feb 07 '24 Sale 572.61 12,000 6,871,319 79,247 Feb 09 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Option Exercise 253.92 11,636 2,954,645 21,686 Dec 08 05:00 PM POLEWACZYK JAMES F Executive Vice President Dec 07 '23 Sale 521.79 11,636 6,071,500 10,050 Dec 08 05:00 PM MAZELSKY JONATHAN JAY President and CEO Dec 04 '23 Option Exercise 79.54 13,424 1,067,745 86,361 Dec 06 05:01 PM MAZELSKY JONATHAN JAY President and CEO Dec 04 '23 Sale 513.05 7,128 3,657,049 79,233 Dec 06 05:01 PM Lane Michael Executive Vice President Nov 07 '23 Option Exercise 133.76 1,728 231,142 5,774 Nov 08 05:09 PM Smith Martin Alexander Executive Vice President Sep 01 '23 Option Exercise 0.00 19 0 226 Sep 06 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 31 '23 Option Exercise 79.54 13,424 1,067,745 86,349 Sep 05 05:01 PM MAZELSKY JONATHAN JAY President and CEO Aug 31 '23 Sale 512.01 13,424 6,873,267 72,925 Sep 05 05:01 PM POLEWACZYK JAMES F Executive Vice President Aug 29 '23 Option Exercise 144.21 16,909 2,438,478 32,947 Aug 31 05:17 PM POLEWACZYK JAMES F Executive Vice President Aug 29 '23 Sale 510.56 22,909 11,696,446 10,038 Aug 31 05:17 PM MAZELSKY JONATHAN JAY President and CEO Aug 05 '23 Option Exercise 0.00 384 0 73,095 Aug 08 05:59 PM MCKEON BRIAN P EVP, CFO and Treasurer Aug 05 '23 Option Exercise 0.00 192 0 29,809 Aug 08 05:59 PM Lane Michael Executive Vice President Aug 03 '23 Option Exercise 187.47 16,027 3,004,598 20,061 Aug 07 05:04 PM Lane Michael Executive Vice President Aug 03 '23 Sale 510.00 16,027 8,173,770 4,034 Aug 07 05:04 PM AYERS JONATHAN W Director May 19 '23 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 19 '23 Sale 491.35 10,000 4,913,502 137,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 '23 Option Exercise 79.54 10,000 795,400 147,039 May 22 05:00 PM AYERS JONATHAN W Director May 18 '23 Sale 489.23 10,000 4,892,268 137,039 May 22 05:00 PM Vandebroek Sophie V. Director May 11 '23 Option Exercise 0.00 344 0 1,216 May 15 05:32 PM COLLINS Asha Director May 11 '23 Option Exercise 0.00 344 0 522 May 15 05:31 PM ESSIG STUART Director May 11 '23 Option Exercise 0.00 344 0 1,717 May 15 05:31 PM Kingsley Lawrence D Director May 11 '23 Option Exercise 0.00 464 0 8,544 May 15 05:32 PM SZOSTAK M ANNE Director May 11 '23 Option Exercise 0.00 344 0 1,604 May 15 05:32 PM AYERS JONATHAN W Director May 11 '23 Option Exercise 0.00 344 0 140,553 May 15 05:31 PM AYERS JONATHAN W Director May 10 '23 Option Exercise 178.26 560 99,826 141,894 May 11 05:01 PM Underberg Sharon E. EVP, GC & Corporate Secretary May 05 '23 Option Exercise 206.94 483 99,952 4,245 May 08 05:04 PM MCKEON BRIAN P EVP, CFO and Treasurer May 05 '23 Option Exercise 178.26 560 99,826 29,605 May 08 05:02 PM SZOSTAK M ANNE Director May 05 '23 Sale 474.89 2,000 949,789 4,700 May 08 05:03 PM Lane Michael Executive Vice President May 05 '23 Sale 484.00 1,000 484,000 4,022 May 08 05:01 PM Vandebroek Sophie V. Director May 04 '23 Option Exercise 206.62 2,187 451,878 3,059 May 05 06:01 PM MAZELSKY JONATHAN JAY President and CEO May 04 '23 Option Exercise 178.26 560 99,826 73,301 May 05 06:00 PM Vandebroek Sophie V. Director May 04 '23 Sale 469.02 2,187 1,025,740 872 May 05 06:01 PM
Index -
P/E -
EPS (ttm) -0.58
Insider Own 9.39%
Shs Outstand 64.39M
Perf Week -20.83%
Market Cap 110.21M
Forward P/E -
EPS next Y -0.45
Insider Trans 0.00%
Shs Float 58.40M
Perf Month -40.00%
Income -36.90M
PEG -
EPS next Q -0.14
Inst Own 47.09%
Short Float 5.16%
Perf Quarter -45.89%
Sales 0.01M
P/S 11020.95
EPS this Y -5.17%
Inst Trans -1.73%
Short Ratio 6.69
Perf Half Y 48.70%
Book/sh 0.60
P/B 2.87
EPS next Y 25.82%
ROA -75.98%
Short Interest 3.01M
Perf Year 24.82%
Cash/sh 0.65
P/C 2.64
EPS next 5Y -
ROE -90.73%
52W Range 1.11 - 3.53
Perf YTD -27.54%
Dividend Est. -
P/FCF -
EPS past 5Y 13.11%
ROI -95.89%
52W High -51.56%
Beta 2.27
Dividend TTM -
Quick Ratio 6.41
Sales past 5Y -53.76%
Gross Margin -8120.58%
52W Low 54.05%
ATR (14) 0.21
Dividend Ex-Date -
Current Ratio 6.41
EPS Y/Y TTM 34.31%
Oper. Margin -392754.59%
RSI (14) 27.60
Volatility 10.84% 9.15%
Employees 35
Debt/Eq 0.02
Sales Y/Y TTM -86.67%
Profit Margin -368997.80%
Recom 1.25
Target Price 7.00
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q 27.09%
Payout -
Rel Volume 1.21
Prev Close 1.86
Sales Surprise -
EPS Surprise 8.20%
Sales Q/Q -
Earnings May 09 BMO
Avg Volume 450.34K
Price 1.71
SMA20 -30.61%
SMA50 -37.27%
SMA200 -17.43%
Trades
Volume 546,367
Change -7.82%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-22-23 Initiated
CapitalOne
Overweight
$12
Nov-12-21 Upgrade
Jefferies
Hold → Buy
$3 → $4
Nov-14-19 Initiated
ROTH Capital
Buy
$12
Aug-05-19 Downgrade
SunTrust
Buy → Hold
$23 → $5
Aug-05-19 Downgrade
Piper Jaffray
Overweight → Neutral
$20 → $6
Aug-05-19 Downgrade
Jefferies
Buy → Hold
Apr-12-19 Initiated
Piper Jaffray
Overweight
$20
Dec-18-18 Initiated
H.C. Wainwright
Buy
$24
Jul-26-16 Initiated
SunTrust
Buy
Mar-17-15 Reiterated
Stifel
Buy
$13 → $14
Apr-25-24 07:00AM
Mar-28-24 10:12AM
02:10AM
(Thomson Reuters StreetEvents)
Mar-27-24 11:53AM
10:31AM
07:14AM
Loading…
07:14AM
(Associated Press Finance)
07:00AM
Mar-21-24 08:50AM
Mar-13-24 07:00AM
Feb-26-24 07:00AM
Feb-12-24 07:00AM
Jan-04-24 07:00AM
Jan-03-24 07:00AM
Dec-10-23 12:00PM
Nov-09-23 07:00AM
08:51AM
Loading…
Nov-05-23 08:51AM
Nov-04-23 01:48AM
(Thomson Reuters StreetEvents)
Nov-03-23 10:33AM
07:07AM
(Associated Press Finance)
07:00AM
Oct-23-23 08:30AM
Oct-20-23 07:00AM
Sep-06-23 07:00AM
Sep-05-23 07:00AM
Aug-17-23 07:00AM
Aug-02-23 07:17AM
(Associated Press Finance)
07:00AM
Jul-19-23 07:00AM
Jul-13-23 09:29AM
Jun-26-23 08:00AM
08:00AM
Loading…
Jun-15-23 08:00AM
Jun-12-23 11:13AM
May-31-23 07:00AM
May-16-23 10:37AM
May-03-23 10:17PM
(Thomson Reuters StreetEvents)
07:23AM
07:00AM
Apr-26-23 07:00AM
Apr-19-23 10:20AM
Apr-05-23 01:45PM
Mar-31-23 04:30AM
Mar-29-23 07:00AM
Mar-21-23 06:23AM
Mar-20-23 06:35AM
Mar-17-23 06:47AM
Mar-16-23 07:00AM
06:51AM
Mar-15-23 06:44AM
Mar-13-23 06:32AM
Mar-10-23 07:04AM
Mar-09-23 06:33AM
Mar-08-23 06:30AM
Mar-07-23 06:34AM
Mar-06-23 07:22AM
Mar-03-23 06:38AM
Mar-02-23 06:44AM
Mar-01-23 07:00AM
06:01AM
06:01AM
Feb-28-23 06:43AM
Feb-27-23 06:50AM
Feb-24-23 07:17AM
07:17AM
Feb-16-23 08:00AM
Feb-15-23 08:00AM
Feb-14-23 06:23AM
Feb-06-23 07:00AM
Jan-22-23 07:30AM
07:24AM
Dec-30-22 07:17AM
Dec-28-22 06:58AM
Dec-26-22 07:14AM
Dec-19-22 09:40AM
Dec-12-22 07:00AM
Dec-02-22 01:18PM
09:40AM
Nov-23-22 09:55AM
Nov-16-22 09:40AM
Nov-12-22 07:14AM
Nov-10-22 09:12AM
(Simply Wall St.) +19.48%
Nov-09-22 07:00AM
Nov-08-22 04:05PM
Nov-03-22 09:00AM
Nov-02-22 07:00AM
Oct-10-22 11:57PM
(The Wall Street Journal)
Oct-04-22 12:00PM
Sep-09-22 08:30AM
Sep-07-22 07:00AM
Sep-06-22 07:00AM
Aug-09-22 12:00PM
Aug-03-22 02:00PM
07:00AM
Jul-27-22 04:00PM
Jul-18-22 10:22AM
(Simply Wall St.) +10.74%
Jun-03-22 08:36AM
(Simply Wall St.) +11.77%
Jun-02-22 04:00PM
Apr-28-22 06:30PM
07:30AM
Apr-25-22 09:00AM
Mar-08-22 04:30PM
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rock Edwin Chief Medical Officer Sep 22 '23 Buy 1.38 30,403 41,956 375,403 Sep 25 04:21 PM Rock Edwin Chief Medical Officer Sep 21 '23 Buy 1.38 35,000 48,300 345,000 Sep 25 04:21 PM Koenig Scott Director Jun 01 '23 Option Exercise 0.60 21,000 12,600 36,750 Jun 02 04:10 PM Hahn Brian M. SVP Finance, CFO May 17 '23 Sale 1.95 3,700 7,215 53,143 May 18 04:27 PM JUNIUS DANIEL M Director May 10 '23 Buy 1.56 30,000 46,800 93,250 May 11 05:08 PM Johnson Bruce S SVP & Chief Commercial Officer May 08 '23 Buy 1.57 13,500 21,195 138,980 May 09 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite